Skip to main content
logo
Bausch Health Companies Inc. (FRA:BVF)
Germany flag Germany · Delayed Price · Currency is EUR
4.777
+0.027 (0.56%)
At close: Feb 20, 2026

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Salix Revenue
2.58B2.33B
Salix Revenue Growth
10.50%3.69%
International Rx Revenue
1.13B1.11B
International Rx Revenue Growth
1.89%3.74%
Solta Medical Revenue
518.00M440.00M
Solta Medical Revenue Growth
17.73%26.80%
Diversified Products Revenue
937.00M950.00M
Diversified Products Revenue Growth
-1.37%0.74%
Bausch + Lomb Revenue
5.10B4.79B
Bausch + Lomb Revenue Growth
6.47%15.56%
Revenue (Other)
--
Revenue (Total)
10.27B9.63B
Revenue (Total) Growth
6.66%9.91%

EBIT

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16 Dec '15 Dec '14
Salix Segment Profit
1.93B1.60B
Salix Segment Profit Growth
20.16%3.49%
International Rx Segment Profit
334.00M376.00M
International Rx Segment Profit Growth
-11.17%12.24%
Solta Medical Segment Profit
232.00M213.00M
Solta Medical Segment Profit Growth
8.92%32.30%
Diversified Products Segment Profit
627.00M626.00M
Diversified Products Segment Profit Growth
0.16%6.83%
Bausch + Lomb Segment Profit
1.13B1.11B
Bausch + Lomb Segment Profit Growth
1.53%13.06%
Operating Income (Total)
1.81B1.55B
Operating Income (Total) Growth
17.27%60.54%
Updated Dec 31, 2025. Data Source: Fiscal.ai.